A regular Meeting of Shareholders of Farmak JSC was held on March 19, 2014.
Director General of Farmak JSC, Filya Zhebrovska, spoke at the meeting of the participants reporting on the Company’s activities in the year 2013 and covering the main development activities of Farmak JSC for the year 2014.
The Chairman of Supervisory Board, Pavlo Zebrivsky, in his speech highly appreciated the Company’s activities in the year 2013. Viktoria Smarodina, Chief Financial Officer, and Dmytro Taranchuk, Head of Legal Department, also reported on the issues on the meeting agenda.
All the issues on the agenda of a regular Meeting of Shareholders of Farmak JSC have been determined.
According to the decision of economic courts of all instances (2009-2010), the name “Corvalol” (“Corvalolum”) was used exclusively by one manufacturer as the name of the medicinal product. Information that Corvalol was manufactured by 70 pharmaceutical enterprises of the USSR is not true. In the middle of 20th century, Lomonosov Kyiv Chemical and Pharmaceuti...
On October 30 the next court hearing was held in the case regarding the well-known trademark Corvalol Corvalolum. During the court hearing, after having heard the parties’ arguments and a complete and unbiased analysis of the case-file, the Economic Court ruled to dismiss the claim of Pharmaceutical Firm “Darnitsa” against the Ministry of Economic Deve...
Farmak was granted 7 awards in the contest “Best Corporate Media of Ukraine 2019” held by the Association of Corporate Media of Ukraine. The jury consisted of professionals granted the Grand Prix as the highest award to the corporate newspaper “Farmak Life” and the Company’s website. They were awarded with the title “Best Corpmedia Ukraine […]